SBI Life Insurance Company / Q3-FY26

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Positive2026-01-23Back to SBILIFE

Revenue

Pending

verification pending

Revenue YoY

reported change

EBITDA

Pending

latest reported figure

Source

bse pending

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
PAT (₹ Cr)PositiveWatchNegative
12 actual records
Actual quarterly PAT (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q1 FY24: 380 · Watch source sentiment · 2023-07-20Q1 FY24Q2 FY24: 760 · Positive source sentiment · 2023-10-27Q2 FY24Q3 FY24: 1,080 · Positive source sentiment · 2024-01-24Q3 FY24Q4 FY24: 1,890 · Positive source sentiment · 2024-04-30Q4 FY24Q1 FY25: 520 · Positive source sentiment · 2024-07-31Q1 FY25Q2 FY25: 1,050 · Watch source sentiment · 2024-10-22Q2 FY25Q3 FY25: 1,600 · Positive source sentiment · 2025-01-20Q3 FY25Q4 FY25: 2,413 · Positive source sentiment · 2025-04-01Q4 FY25Q1 FY26: 594 · Positive source sentiment · 2025-07-30Q1 FY26Q2 FY26: 1,089 · Positive source sentiment · 2025-10-23Q2 FY26Q3 FY26: 1,670 · Positive source sentiment · 2026-01-23Q3 FY26Q4 FY26: 2,470 · Positive source sentiment · 2026-04-30Q4 FY262,470380
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

SBI Life delivered a strong Q3 FY26 with new business premium of INR 31,330 crore (+19% YoY) and individual APE growth of 15%. PAT grew 4% to INR 1,670 crore, impacted by GST and labor law changes (INR 135 crore one-time). VNB margins held at 27.2% (+34bps YoY), within the guided 26-28% range, aided by favorable product mix shift towards protection and par products. The company maintained its private market share leadership at 25.6% in IRP. Management reiterated full-year APE growth guidance of 13-14% and VNB margin guidance of 27-28%. Key risks include persistency pressure in older cohorts (61-month) and potential regulatory changes on commission caps. Overall, disciplined execution and strong distribution momentum support a positive outlook.

Colored figures show movement against the previous available record.

Guidance to track

  • Management reiterated full-year APE growth guidance of 13-14%, with Q4 expected to be lower in absolute terms but growth rate positive.
  • Management guided VNB margin to remain in the 27-28% range for the coming quarter, despite GST impact of ~30-40 bps net of product mix.
  • Management indicated that FY27 growth will not be lower than the current growth rate, though formal guidance will be provided later.

Risks flagged

  • 61-month persistency declined due to COVID cohort impact; management expects this to be the last affected cohort but remains a watch item.
  • Analyst raised concerns about potential commission caps; management acknowledged readiness but no specific impact quantified.
  • Solvency ratio fell to 1.91 (multi-year low) due to strong protection growth and sum assured expansion; dividend payout may pressure further.

Key quotes

  • Our assets under management surpassed INR 5 trillion, reflecting sustained customer confidence and long-term value creation driven by disciplined execution.
  • We continue to stick to our guidance of between 27% and 28% in the coming quarter also.
  • The impact that we're going to get on the new business on account of GST, the 150 basis points will get offset mostly by the better product mix... and balance remain will be approximately 30-40 basis points at end of this year.

Research modules

Go one layer deeper.